02:33 , Jul 13, 2019 |  BioCentury  |  Finance

How crossover, insider support and big money correlated with performance across 1H19 IPOs

The performance of 1H19 IPOs point toward a continuation of a dual-class system where biotechs backed by deep-pocketed VCs and crossover investors can tap the public market at will and generate stronger after-market performance than...
16:42 , Oct 26, 2018 |  BC Week In Review  |  Financial News

First close for China Everbright’s new healthcare fund

China Everbright Ltd. (HKSE:165) completed the first close of its third healthcare fund, raising more than RMB800 million ($115.4 million). The CEL Healthcare Fund III's target is RMB1.5 billion ($216.3 million). According to China Everbright,...
18:23 , Oct 23, 2018 |  BC Extra  |  Financial News

First close for China Everbright’s new healthcare fund

China Everbright Ltd. (HKSE:165) completed the first close of its third healthcare fund, raising more than RMB800 million ($115.4 million). The CEL Healthcare Fund III's target size is RMB1.5 billion ($216.3 million). According to China...
22:14 , Oct 2, 2018 |  BC Extra  |  Company News

Management tracks: Synlogic, Trevena, Editas

Synlogic Inc. (NASDAQ:SYBX) promoted Aoife Brennan to president and CEO. She has held both positions on an interim basis since May, when former President and CEO Jose Carlos Gutiérrez-Ramos resigned. Brennan had been CMO of...
00:06 , Jun 28, 2018 |  BC Extra  |  Company News

Management tracks: Arrakis, Astellas

Arrakis Therapeutics Inc. (Waltham, Mass.) founder and CSO Russ Petter is transitioning to Jennifer Petter. The news was announced in a blog post by Chairman and CEO Michael Gilman. "The support for this transition at...
22:00 , Jun 18, 2018 |  BC Extra  |  Company News

Management tracks: Ionis, Albireo

Ionis Pharmaceuticals Inc. (NASDAQ:IONS) hired Damien McDevitt as CBO. He was SVP of corporate development at Acadia Pharmaceuticals Inc. (NASDAQ:ACAD). Hepatic disease company Albireo Pharma Inc. (NASDAQ:ALBO) hired Jason Duncan as general counsel. He was...
21:15 , May 18, 2018 |  BioCentury  |  Finance

China comes to Europe

  The historically underfunded European biotech sector is in the early stages of tapping into a new stream of capital thanks to the explosion of biomedical innovation in China, which has spawned a wave of...
20:34 , Apr 27, 2018 |  BC Week In Review  |  Financial News

Rare disease company Eloxx raises $50M, lists on NASDAQ

Rare and ultra-rare premature stop codon diseases company Eloxx Pharmaceuticals Inc. (NASDAQ:ELOX) raised $50 million in an April 26 follow-on and began trading on NASDAQ. The company sold 5.1 million shares at $9.75. Citigroup, Piper...
23:45 , Sep 27, 2017 |  BC Extra  |  Company News

Management tracks: Gilead, Tango, Rubius, Bicycle

Gilead Sciences Inc. (NASDAQ:GILD) said COO Kevin Young will retire, effective early 2018. Young returned to Gilead as COO in May 2016 after brief retirement during which he acted as an advisor. He was Gilead's...
21:28 , Jun 16, 2017 |  BC Week In Review  |  Financial News

Eloxx raises $24M in series C

On June 8, genetic diseases company Eloxx Pharmaceuticals Ltd. (Rehovot, Israel) raised $24 million in a series C round led by Pontifax, according to two of its investors. Quark Venture and GF Capital said they...